531050 Sigma-AldrichPFKFB3 Inhibitor III, YN1 - CAS 75187-63-2 - Calbiochem
A cell-permeable, potent and competitive inhibitor of fructose-2,6-bisphosphatase 3 (PFKFB3; IC₅₀ = 670 nM).
More>> A cell-permeable, potent and competitive inhibitor of fructose-2,6-bisphosphatase 3 (PFKFB3; IC₅₀ = 670 nM). Less<<Sinónimos: 7,8-Dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one, 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 Inhibitor, YN1
Productos recomendados
Descripción
| Replacement Information | 
|---|
Tabla espec. clave
| CAS # | Empirical Formula | 
|---|---|
| 75187-63-2 | C₁₅H₁₀O₅ | 
Precios y disponibilidad
| Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
|---|---|---|---|---|---|---|
| 5.31050.0001 | 
 | Frasco de vidrio | 25 mg | 
 | — | 
| References | |
|---|---|
| References | Klarer, A. C., et al. 2014. Cancer Metab. 2, 2. Seo, M., et al. 2011. PLoS ONE 6, e24179. | 
| Product Information | |
|---|---|
| CAS number | 75187-63-2 | 
| Form | Off-white powder | 
| Hill Formula | C₁₅H₁₀O₅ | 
| Reversible | Y | 
| Quality Level | MQ100 | 
| Applications | 
|---|
| Biological Information | |
|---|---|
| Primary Target | PFKFB3 | 
| Primary Target IC<sub>50</sub> | 670 nM & Ki | 
| Purity | ≥98% by HPLC | 
| Physicochemical Information | |
|---|---|
| Cell permeable | Y | 
| Dimensions | 
|---|
| Materials Information | 
|---|
| Toxicological Information | 
|---|
| Safety Information according to GHS | 
|---|
| Safety Information | 
|---|
| Product Usage Statements | 
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas | 
| Transport Information | 
|---|
| Supplemental Information | 
|---|
| Specifications | 
|---|
| Global Trade Item Number | |
|---|---|
| Número de referencia | GTIN | 
| 5.31050.0001 | 04055977242522 | 
Documentation
PFKFB3 Inhibitor III, YN1 - CAS 75187-63-2 - Calbiochem Ficha datos de seguridad (MSDS)
| Título | 
|---|
Referencias bibliográficas
| Visión general referencias | 
|---|
| Klarer, A. C., et al. 2014. Cancer Metab. 2, 2. Seo, M., et al. 2011. PLoS ONE 6, e24179. | 

 


 
  

 

 
